| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9664 |
| Human Intestinal Absorption | HIA+ | 0.9925 |
| Caco-2 Permeability | Caco2+ | 0.7962 |
| P-glycoprotein Substrate | Non-substrate | 0.5711 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8782 |
| Non-inhibitor | 0.9574 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7750 |
| Distribution |
| Subcellular localization | Lysosome | 0.8276 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7797 |
| CYP450 2D6 Substrate | Substrate | 0.7109 |
| CYP450 3A4 Substrate | Non-substrate | 0.5507 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9230 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8932 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8388 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8682 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9804 |
| Non-inhibitor | 0.8720 |
| AMES Toxicity | Non AMES toxic | 0.9790 |
| Carcinogens | Non-carcinogens | 0.8079 |
| Fish Toxicity | High FHMT | 0.9270 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9667 |
| Honey Bee Toxicity | High HBT | 0.5449 |
| Biodegradation | Not ready biodegradable | 0.9633 |
| Acute Oral Toxicity | II | 0.5433 |
| Carcinogenicity (Three-class) | Non-required | 0.6960 |